Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017). Emerging biological principles of metastasis. Cell, 168(4), 670–691.
Aguirre-Ghiso, J. A. (2018). How dormant cancer persists and reawakens. Science, 361(6409), 1314–1315.
Banys-Paluchowski, M., Reinhardt, F., & Fehm, T. (2020). Disseminated tumor cells and dormancy in breast cancer progression. Advances in Experimental Medicine and Biology, 122035, 35–43.
Bushnell, G. G., Deshmukh, A. P., den Hollander, P., Luo, M., Soundararajan, R., Jia, D., Levine, H., Mani, S. A., & Wicha, M. S. (2021). Breast cancer dormancy: Need for clinically relevant models to address current gaps in knowledge. NPJ Breast Cancer, 7(1), 66.
Phan, T. G., & Croucher, P. I. (2020). The dormant cancer cell life cycle. Nature Reviews Cancer, 20(7), 398–411.
Gawrzak, S., Rinaldi, L., Gregorio, S., Arenas, E. J., Salvador, F., Urosevic, J., et al. (2018). MSK1 regulates luminal cell differentiation and metastatic dormancy in ER(+) breast cancer. Nature Cell Biology, 20(2), 211–221.
Keydar, I., Chen, L., Karby, S., Weiss, F. R., Delarea, J., Radu, M., Chaitcik, S., & Brenner, H. J. (1979). Establishment and characterization of a cell line of human breast carcinoma origin. European Journal of Cancer, 15(5), 659–670.
Harrell, J. C., Dye, W. W., Allred, D. C., Jedlicka, P., Spoelstra, N. S., Sartorius, C. A., & Horwitz, K. B. (2006). Estrogen receptor positive breast cancer metastasis: Altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes. Cancer Research, 66(18), 9308–9315.
Puchalapalli, M., Zeng, X., Mu, L., Anderson, A., Hix, G. L., Zhang, M., Sayyad, M. R., Mosticone, W. S., Clevenger, C. V., & Koblinski, J. E. (2016). NSG mice provide a better spontaneous model of breast cancer metastasis than athymic (Nude) mice. PLoS ONE, 11(9), e0163521.
Lefley, D., Howard, F., Arshad, F., Bradbury, S., Brown, H., Tulotta, C., Eyre, R., Alférez, D., Wilkinson, J. M., Holen, I., Clarke, R. B., & Ottewell, P. (2019). Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts. Breast Cancer Research, 21(1), 130–1220.
Lu, X., Mu, E., Wei, Y., Riethdorf, S., Yang, Q., Yuan, M., Yan, J., Hua, Y., Tiede, B. J., Lu, X., Haffty, B. G., Pantel, K., Massagué, J., & Kang, Y. (2011). VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging alpha4beta1-positive osteoclast progenitors. Cancer Cell, 20(6), 701–714.
Albrengues, J., Shields, M. A., Ng, D., Park, C. G., Ambrico, A., Poindexter, M. E., et al. (2018). Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science, 361(6409), eaao4227.
Wada, M., Canals, D., Adada, M., Coant, N., Salama, M. F., Helke, K. L., Arthur, J. S., Shroyer, K. R., Kitatani, K., Obeid, L. M., & Hannun, Y. A. (2017). P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment. Oncogene., 36(47), 6649–6657.
Barkan, D., Kleinman, H., Simmons, J. L., Asmussen, H., Kamaraju, A. K., Hoenorhoff, M. J., Liu, Z. Y., Costes, S. V., Cho, E. H., Lockett, S., Khanna, C., Chambers, A. F., & Green, J. E. (2008). Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Research, 68(15), 6241–6250.
Rucci, N., Ricevuto, E., Ficorella, C., Longo, M., Perez, M., Di, G. C., Funari, A., Teti, A., & Migliaccio, S. (2004). In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human breast cancer cells. Bone, 34(4), 697–709.
Sowder, M. E., & Johnson, R. W. (2018). Enrichment and detection of bone disseminated tumor cells in models of low tumor burden. Science Reports, 8(1), 14299.
Carlson, P., Dasgupta, A., Grzelak, C. A., Kim, J., Barrett, A., Coleman, I. M., Shor, R. E., Goddard, E. T., Dai, J., Schweitzer, E. M., Lim, A. R., Crist, S. B., Cheresh, D. A., Nelson, P. S., Hansen, K. C., & Ghajar, C. M. (2019). Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy. Nature Cell Biology, 21(2), 238–250.
Holen, I., Walker, M., Nutter, F., Fowles, A., Evans, C. A., Eaton, C. L., & Ottewell, P. D. (2016). Oestrogen receptor positive breast cancer metastasis to bone: Inhibition by targeting the bone microenvironment in vivo. Clinical and Experimental Metastasis, 33(3), 211–224.
Malladi, S., Macalinao, D. G., Jin, X., He, L., Basnet, H., Zou, Y., De, S. E., & Massagué, J. (2016). Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT. Cell, 165(1), 45–60.
Ghajar, C. M., Peinado, H., Mori, H., Matei, I. R., Evason, K. J., Brazier, H., et al. (2013). The perivascular niche regulates breast tumour dormancy. Nature Cell Biology, 15(7), 807–817.
Gao, H., Chakraborty, G., Lee-Lim, A. P., Mo, Q., Decker, M., Vonica, A., Shen, R., Brogi, E., Brivanlou, A. H., & Giancotti, F. G. (2012). The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell, 150(4), 764–779.
Montagner, M., Bhome, R., Hooper, S., Chakravarty, P., Qin, X., Sufi, J., Bhargava, A., Ratcliffe, C. D. H., Naito, Y., Pocaterra, A., Tape, C. J., & Sahai, E. (2020). Crosstalk with lung epithelial cells regulates Sfrp2-mediated latency in breast cancer dissemination. Nature Cell Biology, 22(3), 289–296.
De Cock, J. M., Shibue, T., Dongre, A., Keckesova, Z., Reinhardt, F., & Weinberg, R. A. (2016). Inflammation triggers Zeb1-dependent escape from tumor latency. Cancer Research, 76(23), 6778–6784.
Piranlioglu, R., Lee, E., Ouzounova, M., Bollag, R. J., Vinyard, A. H., Arbab, A. S., Marasco, D., Guzel, M., Cowell, J. K., Thangaraju, M., Chadli, A., Hassan, K. A., Wicha, M. S., Celis, E., & Korkaya, H. (2019). Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model. Nature Communications, 10(1), 1430.
Luo, X. L., Deng, C. C., Su, X. D., Wang, F., Chen, Z., Wu, X. P., Liang, S. B., Liu, J. H., & Fu, L. W. (2018). Loss of MED12 induces tumor dormancy in human epithelial ovarian cancer via downregulation of EGFR. Cancer Research, 78(13), 3532–3543.
Liang, X., Gu, J., Li, T., Zhao, L., Fu, X., Zhang, W., Wang, J., Shang, Z., Huang, W., & Zhou, J. (2018). PAX5 haploinsufficiency induce cancer cell dormancy in Raji cells. Experimental Cell Research, 367(1), 30–36.
Kleinsmith, L. J., & Pierce, G. B., Jr. (1964). Multipotentiality of single embryonal carcinoma cells. Cancer Research, 24, 1544–1551.
Lawson, M. A., McDonald, M. M., Kovacic, N., Hua, K. W., Terry, R. L., Down, J., Kaplan, W., Paton-Hough, J., Fellows, C., Pettitt, J. A., Neil, D. T., Van, V. E., Baldock, P. A., Rogers, M. J., Eaton, C. L., Vanderkerken, K., Pettit, A. R., Quinn, J. M., Zannettino, A. C., … Croucher, P. I. (2015). Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche. Nature Communications, 6, 8983.
Chery, L., Lam, H. M., Coleman, I., Lakely, B., Coleman, R., Larson, S., Aguirre-Ghiso, J. A., Xia, J., Gulati, R., Nelson, P. S., Montgomery, B., Lange, P., Snyder, L. A., Vessella, R. L., & Morrissey, C. (2014). Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways. Oncotarget, 5(20), 9939–9951.
Sistigu, A., Musella, M., Galassi, C., Vitale, I., & De, M. R. (2020). Tuning cancer fate: Tumor microenvironment’s role in cancer stem cell quiescence and reawakening. Frontiers Immunology, 11, 2166.
Jahangiri, L., & Ishola, T. (2022). Dormancy in breast cancer, the role of autophagy, lncRNAs, miRNAs and exosomes. International Journal of Molecular Science, 23(9), 5271.
Korentzelos, D., Clark, A. M., & Wells, A. (2020). A perspective on therapeutic pan-resistance in metastatic cancer. International Journal of Molecular Science, 21(19), E7304.
Baram, T., Rubinstein-Achiasaf, L., Ben-Yaakov, H., & Ben-Baruch, A. (2021). Inflammation-driven breast tumor cell plasticity: Stemness/EMT, therapy resistance and dormancy. Frontiers Oncology, 10, 614468.
Smart, J. A., Oleksak, J. E., & Hartsough, E. J. (2021). Cell Adhesion Molecules in Plasticity and Metastasis. Molecular Cancer Research, 19(1), 25–37.
Dhaliwal, D., & Shepherd, T. G. (2022). Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: A review. Clinical Experimental Metastasis, 39(2), 291–301.
Stuelten, C. H., Parent, C. A., & Montell, D. J. (2018). Cell motility in cancer invasion and metastasis: Insights from simple model organisms. Nature Reviews Cancer, 18(5), 296–312.
Genna, A., & Gil-Henn, H. (2018). FAK family kinases: The Yin and Yang of cancer cell invasiveness. Molecular and Cellular Oncology, 5(4), e1449584.
Zavyalova, M. V., Denisov, E. V., Tashireva, L. A., Savelieva, O. E., Kaigorodova, E. V., Krakhmal, N. V., & Perelmuter, V. M. (2019). Intravasation as a key step in cancer metastasis. Biochemistry (Mosc), 84(7), 762–772.
Tajbakhsh, A., Rivandi, M., Abedini, S., Pasdar, A., & Sahebkar, A. (2019). Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC): A review. Critical Reviews in Oncology and Hematology, 140, 17–27.
Adeshakin, F. O., Adeshakin, A. O., Afolabi, L. O., Yan, D., Zhang, G., & Wan, X. (2021). Mechanisms for modulating anoikis resistance in cancer and the relevance of metabolic reprogramming. Frontiers Oncology, 11, 626577.
Khan, S. U., Fatima, K., & Malik, F. (2022). Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis. Clinical and Experimental Metastasis, 39(5), 715–726.
Liu, Y., Zhang, Y., Ding, Y., & Zhuang, R. (2021). Platelet-mediated tumor metastasis mechanism and the role of cell adhesion molecules. Critical Reviews in Oncology and Hematology, 167, 103502.
Reduzzi, C., Vismara, M., Gerratana, L., Silvestri, M., De, B. F., Raspagliesi, F., Verzoni, E., Di, C. S., Locati, L. D., Cristofanilli, M., Daidone, M. G., & Cappelletti, V. (2020). The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells. Seminars in Cancer Biology, 60, 344–350.
Hamilton, G., & Rath, B. (2017). Circulating tumor cell interactions with macrophages: Implications for biology and treatment. Translational Lung Cancer Research, 6(4), 418–430.
Banys, M., Krawczyk, N., & Fehm, T. (2014). The role and clinical relevance of disseminated tumor cells in breast cancer. Cancers (Basel), 6(1), 143–152.
Linde, N., Fluegen, G., & Aguirre-Ghiso, J. A. (2016). The relationship between dormant cancer cells and their microenvironment. Advances in Cancer Reseach, 13, 245–71.
Ring, A., Spataro, M., Wicki, A., & Aceto, N. (2022). Clinical and biological aspects of disseminated tumor cells and dormancy in breast cancer. Frontiers in Cell and Developmental Biology, 10, 929893.
Illyes, I., Tokes, A. M., Kovacs, A., Szasz, A. M., Molnar, B. A., Molnar, I. A., Kaszas, I., Baranyak, Z., Laszlo, Z., Kenessey, I., & Kulka, J. (2014). In breast cancer patients sentinel lymph node metastasis characteristics predict further axillary involvement. Virchows Archives, 465(1), 15–24.
留言 (0)